TY - JOUR
T1 - Breast cancer screening and diagnosis
T2 - A synopsis of the european breast guidelines
AU - Schünemann, Holger J.
AU - Lerda, Donata
AU - Quinn, Cecily
AU - Follmann, Markus
AU - Alonso-Coello, Pablo
AU - Rossi, Paolo Giorgi
AU - Lebeau, Annette
AU - Nyström, Lennarth
AU - Broeders, Mireille
AU - Ioannidou-Mouzaka, Lydia
AU - Duffy, Stephen W.
AU - Borisch, Bettina
AU - Fitzpatrick, Patricia
AU - Hofvind, Solveig
AU - Castells, Xavier
AU - Giordano, Livia
AU - Canelo-Aybar, Carlos
AU - Warman, Sue
AU - Mansel, Robert
AU - Sardanelli, Francesco
AU - Parmelli, Elena
AU - Gräwingholt, Axel
AU - Saz-Parkinson, Zuleika
N1 - Publisher Copyright:
© 2019 American College of Physicians.
PY - 2020/1/7
Y1 - 2020/1/7
N2 - Description: The European Commission Initiative for Breast Cancer Screening and Diagnosis guidelines (European Breast Guidelines) are coordinated by the European Commission's Joint Research Centre. The target audience for the guidelines includes women, health professionals, and policymakers. Methods: An international guideline panel of 28 multidisciplinary members, including patients, developed questions and corresponding recommendations that were informed by systematic reviews of the evidence conducted between March 2016 and December 2018. GRADE (Grading of Recommendations Assessment, Development and Evaluation) Evidence to Decision frameworks were used to structure the process and minimize the influence of competing interests by enhancing transparency. Questions and recommendations, expressed as strong or conditional, focused on outcomes that matter to women and provided a rating of the certainty of evidence. Recommendations: This synopsis of the European Breast Guidelines provides recommendations regarding organized screening programs for women aged 40 to 75 years who are at average risk. The recommendations address digital mammography screening and the addition of hand-held ultrasonography, automated breast ultrasonography, or magnetic resonance imaging compared with mammography alone. The recommendations also discuss the frequency of screening and inform decision making for women at average risk who are recalled for suspicious lesions or who have high breast density.
AB - Description: The European Commission Initiative for Breast Cancer Screening and Diagnosis guidelines (European Breast Guidelines) are coordinated by the European Commission's Joint Research Centre. The target audience for the guidelines includes women, health professionals, and policymakers. Methods: An international guideline panel of 28 multidisciplinary members, including patients, developed questions and corresponding recommendations that were informed by systematic reviews of the evidence conducted between March 2016 and December 2018. GRADE (Grading of Recommendations Assessment, Development and Evaluation) Evidence to Decision frameworks were used to structure the process and minimize the influence of competing interests by enhancing transparency. Questions and recommendations, expressed as strong or conditional, focused on outcomes that matter to women and provided a rating of the certainty of evidence. Recommendations: This synopsis of the European Breast Guidelines provides recommendations regarding organized screening programs for women aged 40 to 75 years who are at average risk. The recommendations address digital mammography screening and the addition of hand-held ultrasonography, automated breast ultrasonography, or magnetic resonance imaging compared with mammography alone. The recommendations also discuss the frequency of screening and inform decision making for women at average risk who are recalled for suspicious lesions or who have high breast density.
UR - https://www.scopus.com/pages/publications/85077931254
U2 - 10.7326/M19-2125
DO - 10.7326/M19-2125
M3 - Article
C2 - 31766052
AN - SCOPUS:85077931254
SN - 0003-4819
VL - 172
SP - 46
EP - 56
JO - Annals of Internal Medicine
JF - Annals of Internal Medicine
IS - 1
ER -